Evidence map›Paper›PMID 35069519›Full record

ArticleFrontiers in immunology2021

Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation.

Felix B He, Hira Khan, Moona Huttunen, Pekka Kolehmainen, Krister Melén, Sari Maljanen, Mengmeng Qu, Miao Jiang, Laura Kakkola, Ilkka Julkunen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Reverse Genetics Systems for Filoviruses.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  7. Emerging microbes & infections · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Felix B HeInstitute of Biomedicine/Virology, University of Turku, Turku, Finland.
Hira KhanInstitute of Biomedicine/Virology, University of Turku, Turku, Finland.
Moona HuttunenInstitute of Biomedicine/Virology, University of Turku, Turku, Finland.
Pekka KolehmainenInstitute of Biomedicine/Virology, University of Turku, Turku, Finland.
Krister MelénExpert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Sari MaljanenInstitute of Biomedicine/Virology, University of Turku, Turku, Finland.
Mengmeng QuResearch Center for Clinical & Translational Medicine, Fifth Medical Center for General Hospital of People's Liberation Army (PLA), Beijing, China.
Miao JiangExpert Microbiology Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Laura KakkolaInstitute of Biomedicine/Virology, University of Turku, Turku, Finland.
Ilkka JulkunenInstitute of Biomedicine/Virology, University of Turku, Turku, Finland.
University of Turku · FIFinnish Institute for Health and Welfare · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Filovirus family consists of highly pathogenic viruses that have caused fatal outbreaks especially in many African countries. Previously, research focus has been on Ebola, Sudan and Marburg viruses leaving other filoviruses less well studied. Filoviruses, in general, pose a significant global threat since they are highly virulent and potentially transmissible between humans causing sporadic infections and local or widespread epidemics. Filoviruses have the ability to downregulate innate immunity, and especially viral protein 24 (VP24), VP35 and VP40 have variably been shown to interfere with interferon (IFN) gene expression and signaling. Here we systematically analyzed the ability of VP24 proteins of nine filovirus family members to interfere with retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated antigen 5 (MDA5) induced IFN-β and IFN-λ1 promoter activation. All VP24 proteins were localized both in the cell cytoplasm and nucleus in variable amounts. VP24 proteins of Zaire and Sudan ebolaviruses, Lloviu, Taï Forest, Reston, Marburg and Bundibugyo viruses (EBOV, SUDV, LLOV, TAFV, RESTV, MARV and BDBV, respectively) were found to inhibit both RIG-I and MDA5 stimulated IFN-β and IFN-λ1 promoter activation. The inhibition takes place downstream of interferon regulatory factor 3 phosphorylation suggesting the inhibition to occur in the nucleus. VP24 proteins of Mengla (MLAV) or Bombali viruses (BOMV) did not inhibit IFN-β or IFN-λ1 promoter activation. Six ebolavirus VP24s and Lloviu VP24 bound tightly, whereas MARV and MLAV VP24s bound weakly, to importin α5, the subtype that regulates the nuclear import of STAT complexes. MARV and MLAV VP24 binding to importin α5 was very weak. Our data provides new information on the innate immune inhibitory mechanisms of filovirus VP24 proteins, which may contribute to the pathogenesis of filovirus infections.

Indexed as

Cell Line, TumorDEAD Box Protein 58FiloviridaeGene Expression RegulationHEK293 CellsHumansInterferon-Induced Helicase, IFIH1Interferon LambdaInterferonsInterferon Type IInterleukinsPromoter Regions, GeneticReceptors, ImmunologicViral ProteinsDEAD Box Protein 58IFIH1 protein, humanInterferon-Induced Helicase, IFIH1Interferon Lambdainterferon-lambda, humanInterferonsInterferon Type IInterleukinsReceptors, ImmunologicRIGI protein, humanViral Proteinsebolavirusfilovirusinnate immunityMDA5 pathwayRIG-I pathwaytype III interferontype I interferonVP24

Identifiers

PMID35069519
PMCPMC8767557
OpenAlexW4205875722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.